DuPont Reports First Quarter 2021 Results
- 1Q21 GAAP EPS from continuing operations of $0.89; adjusted EPS of $0.91
- 1Q21 Net Sales of $4.0 billion, up 8 percent; organic sales up 7 percent versus the year-ago period
- 1Q21 GAAP Income from continuing operations of $541 million; operating EBITDA of $1.05 billion, up 15 percent versus the year-ago period
- Earnings leverage of 1.9 times driving operating EBITDA margin expansion of 160 basis points
- Approximately $660 million of capital returned to shareholders during the quarter through share repurchases and dividends
- Raises full year 2021 guidance for net sales, operating EBITDA and adjusted EPS
News provided by
Share this article
Share this article
DuPont Reports First Quarter 2021 Results prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
DuPont Announces Final Results of Exchange Offer in Connection with IFF Transaction
February 3, 2021 GMT
DuPont Logo (PRNewsfoto/DuPont)
WILMINGTON, Del., Feb. 3, 2021 /PRNewswire/ DuPont (NYSE: DD) announced today the final results of its exchange offer, and the final proration factor of 52.5307455 percent, in connection with the previously announced separation of its nutrition and biosciences business (the “N&B Business”) and merger of Nutrition & Biosciences, Inc. (“N&B”), a DuPont subsidiary formed to hold the N&B Business, with a subsidiary of International Flavors & Fragrances Inc. (“IFF”) (NYSE: IFF).
Press release content from PR Newswire. The AP news staff was not involved in its creation.
DuPont Announces Preliminary Results of Exchange Offer in Connection with IFF Transaction
February 1, 2021 GMT
DuPont Logo (PRNewsfoto/DuPont)
WILMINGTON, Del., Feb. 1, 2021 /PRNewswire/ DuPont (NYSE: DD) announced today the preliminary results of its exchange offer in connection with the previously announced separation of its nutrition and biosciences business (the “N&B Business”) and merger of Nutrition & Biosciences, Inc. (“N&B”), a DuPont subsidiary formed to hold the N&B Business, with a subsidiary of International Flavors & Fragrances Inc. (“IFF”) (NYSE: IFF). DuPont intends to accept, subject to proration, shares of DuPont common stock validly tendered in the exchange offer.
DuPont Reports Preliminary Q4 Results
WILMINGTON (dpa-AFX) - DuPont (DD) said it expects fourth quarter adjusted EPS to be in the range of $0.93 to $0.95 on net sales of approximately $5.25 billion. For full year 2020, the company anticipates adjusted EPS to be in the range of $3.34 to $3.36 on net sales of approximately $20.40 billion.
On December 31, 2020, the company commenced its exchange offer whereby DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences, Inc. common stock. The Exchange Offer will expire on January 29, 2021.
DuPont will announce its financial results for the fourth quarter and full year on February 9, 2021.